Home
About
Overview
Sharing Data
ORCID
Help
History (42)
Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control.
Kenton, Kimberly
Ureterolithiasis
Pigmentary macular degeneration with multifocal necrotizing encephalopathy.
Adjuvant aromatase inhibitors: are we there yet?
See All 42 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Adjuvant aromatase inhibitors: are we there yet?
Adjuvant aromatase inhibitors: are we there yet? Cancer. 2003 Nov 01; 98(9):1779-81.
View in:
PubMed
subject areas
Antineoplastic Agents, Hormonal
Aromatase Inhibitors
Breast Neoplasms
Chemotherapy, Adjuvant
Clinical Trials as Topic
Disease-Free Survival
Enzyme Inhibitors
Female
Humans
Neoplasms, Hormone-Dependent
Nitriles
Tamoxifen
Triazoles
authors with profiles
Gini Fleming